Patent ID: 8012477

Claim:
A method of treating multiple myeloma, comprising administering to a patient in need thereof a therapeutically effective amount of an IL-17 antibody or antigen binding fragment thereof comprising: a. a heavy (V H ) chain variable domain comprising the amino acid sequence set forth as SEQ ID NO:8; b. a light (V L ) chain variable domain comprising the amino acid sequence set forth as SEQ ID NO:10; c. a heavy (V H ) chain variable domain comprising the amino acid sequence set forth as SEQ ID NO:8 and a light (V L ) chain variable domain comprising the amino acid sequence set forth as SEQ ID NO:10; or d. the three Complementarity-Determining Regions (CDRs) of the amino acid sequence set forth as SEQ ID NO:8 and the three CDRs of the amino acid sequence set forth as SEQ ID NO:10.